CWM
CATX icon

Cornerstone Wealth Management’s Perspective Therapeutics CATX Stock Holding History

Cornerstone Wealth Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,021
Closed -$42K – 383
2019
Q1 		$42K Buy
+1,021
New +$3.98K 0.01% 499

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.66B AUM 17.04% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Cornerstone Wealth Management's CATX Position: Q2 2019 in Review

Cornerstone Wealth Management sold out of Perspective Therapeutics (CATX) in Q2 2019, closing a stake of 1,021 shares — an estimated $42K sold.

Cornerstone Wealth Management first reported a position in CATX in Q1 2019 and held it in 1 quarter. The position peaked at $42K in Q1 2019. 29 funds tracked by Wall St. Rank hold CATX as of Q2 2019.

  • Cornerstone Wealth Management reported no remaining Perspective Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Cornerstone Wealth Management sold 1,021 Perspective Therapeutics shares in Q2 2019, an estimated $42K.
  • Cornerstone Wealth Management first reported a position in Perspective Therapeutics in Q1 2019 and held it in 1 quarter.
  • Cornerstone Wealth Management's Perspective Therapeutics position peaked at $42K in Q1 2019.
  • 29 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2019.

Based on Cornerstone Wealth Management's 13F filing for Q2 2019, filed 2 Aug 2019.